- Published at
- by economictimes.indiatimes.com
positive
positive
Stocks plunged news: Sensex rises! But these stocks are down 5% or more on BSE
In the Nifty pack, 48 stocks were trading in the green, while 2 stocks were trading in the red.
News for CHL Limited (CHLLTD.BO)
- Published at
- by economictimes.indiatimes.com
positivepositiveStocks Surged: Sensex falls! But these stocks are up over 10% on BSE
In the Nifty 50 index, 28 stocks were trading in the green, while 22 stocks were trading in the red.- Published at
- by thehindubusinessline.com
mixedmixedChalet Hotels acquires Courtyard by Marriott Aravali resort, NCR
Chalet Hotels acquires Courtyard by Marriott Aravali Resort, NCR for ₹315 crore, enhancing leisure offerings near Delhi.- Published at
- by moneycontrol.com
neutralneutralCHL Consolidated March 2023 Net Sales at Rs 29.22 crore, up 109.78% Y-o-Y
Net Sales at Rs 29.22 crore in March 2023 up 109.78% from Rs. 13.93 crore in March 2022. Quarterly Net Loss at Rs. 5.42 crore in March 2023 down 36.58% from Rs...- Published at
- by moneycontrol.com
positivepositiveCHL Standalone March 2023 Net Sales at Rs 22.23 crore, up 166.46% Y-o-Y
Net Sales at Rs 22.23 crore in March 2023 up 166.46% from Rs. 8.34 crore in March 2022. Quarterly Net Profit at Rs. 4.56 crore in March 2023 up 134314.71% from...- Published at
- by business-standard.com
mixedmixedChalet Hotels up 6%, hits 52-week high in a weak market on ratings upgrade
The Positive Outlook reflects a consistent recovery in CHL's business operations since 2QFY22, with 1QFY23 revenue and EBITDA exceeding the pre-COVID-19 levels.- Published at
- by financialexpress.com
mixedmixedACC, Cipla, Bharti Airtel, Cipla, Angel One, Tata Elxsi, Jindal Steel and Power, Tata Steel stocks in focus
Indian equity markets are likely to open higher on Friday. SGX Nifty was up with gains signalling that Dalal Street is headed for a positive start, while global cues were mixed.- Published at
- by moneycontrol.com
neutralneutralCHL Standalone March 2022 Net Sales at Rs 8.34 crore, up 43.14% Y-o-Y
Net Sales at Rs 8.34 crore in March 2022 up 43.14% from Rs. 5.83 crore in March 2021. Quarterly Net Loss at Rs. 0.00 crore in March 2022 down 100.3% from Rs. 1...- Published at
- by business-standard.com
positivepositiveCadila Healthcare inks ZyCoV-D commercialisation agreement with Korean firm
Read more about Cadila Healthcare inks ZyCoV-D commercialisation agreement with Korean firm on Business Standard. Cadila will provide manufacturing license and transfer the Plasmid DNA vaccine technology to Enzychem Lifesciences- Published at
- by economictimes.indiatimes.com
mixedmixedCipla Q2 results: Net profit rises 8% to Rs 712 cr; meets D-Street estimate
Revenues for the quarter rose 10.3 per cent YoY to Rs 5,485.84 crore compared with Rs 4,972.58 crore in the same quarter last year.